Marcy B. Bolster, MD is a rheumatologist and the Director of the Rheumatology Fellowship Training Program and a member of the Scleroderma Program at the Massachusetts General Hospital (MGH), Boston, MA. She is a Professor of Medicine at Harvard Medical School. Her clinical interests lie in scleroderma and systemic autoimmune rheumatic diseases. She was a member of the core leadership group for the American College of Rheumatology Interstitial Lung Disease Guidelines working group. She additionally has a strong interest in medical education across the spectrum of learners, and she has helped train more than 70 rheumatology fellows. She is the recipient of the 2019 American College of Rheumatology Distinguished Program Director Award, the 2019 Partners (now Mass General Brigham) Outstanding Program Director Award, and the 2021 Arthritis Foundation Marian Ropes Lifetime Achievement Award.Kristin B. Highland MD, MSCR is Vice Chair of the Integrated Hospital Care Institute (Anesthesiology, Emergency Services, Hospital Medicine, Infectious Disease, and Pulmonary/Critical Care) of the Cleveland Clinic and director of the Rheumatic Lung Disease Program. Her clinical and research interests have focused on the pulmonary manifestations of rheumatic lung disease with an emphasis on interstitial lung disease and pulmonary hypertension, particularly in the setting of scleroderma. She is a member of the scientific advisory council of the Pulmonary Hypertension Association and the Scleroderma Foundation and has been active in the American College of Chest Physicians. She has published more than 100 peer-reviewed articles and serves on the editorial board of several international journals including Lancet Respiratory. She is also an associate editor of Respiratory Medicine.

• 1:Approach to the patient with interstitial lung disease.2:Idiopathic pneumonia with autoimmune features.3: Approach to the patient with pulmonary vascular disease.4: Approach to the patient with neuromuscular weakness.5: Approach to the patient with pleural disease.6: Approach to the patient with obstructive airways disease.7: General care of the patient with pulmonary manifestations of rheumatic disease.8: Pulmonary manifestations of rheumatoid arthritis.9: Pulmonary manifestations of Sjogren’s syndrome.10: Pulmonary manifestations of systemic lupus erythematosus.11: Pulmonary manifestations of the idiopathic inflammatory myopathies.12: Pulmonary manifestations of scleroderma and mixed connective tissue disease.13: Pulmonary manifestations of systemic vasculitis.14: Sarcoidosis.15: Pulmonary manifestations of the spondyloarthropathies.16: Pulmonary manifestations of IgG4-related disease.17: Pulmonary toxicities of medications used for rheumatic diseases